OZOliver Zimmermann

Oliver Zimmermann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oliver Zimmermann has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Jan Torzewski

    Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm

    1 shared publication
  • Magdalena Bienek-Ziolkowski

    Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm

    1 shared publication
  • Matthias Kochs

    Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm

    1 shared publication
  • Nico Merkle

    Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm

    1 shared publication
  • Olaf Grebe

    Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm

    1 shared publication
  • Thorsten Nusser

    Department of Internal Medicine II—Cardiology, University of Ulm , Robert—Koch—Str. 8, 89081, Ulm

    1 shared publication

Latest Publications

  • Myocardial Biopsy Findings and Gadolinium Enhanced Cardiovascular Magnetic Resonance in Dilated Cardiomyopathy

    by Oliver Zimmermann, Olaf Grebe, Nico Merkle, Thorsten Nusser, Matthias Kochs, Magdalena Bienek-Ziolkowski, Vinzenz Hombach, Jan Torzewski

    Background: In some patients suffering from dilated cardiomyopathy (DCM) magnetic resonance imaging (MRI) shows late gadolinium enhancement with variable distribution. Myocardial biopsies in DCM reveal a chronic myocardial inflammatory process in almost 50% and myocardial persistence of adenoviral or enteroviral genome in about 15% of the patients. Aims: We prospectively investigated whether the pattern of late gadolinium enhancement correlates with myocardial biopsy findings. Methods and results: 42 patients with DCM and 42 control subjects underwent contrast MRI. In the DCM group, endomyocardial biopsies were performed and evaluated for inflammation and viral genome. None of the control subjects showed late gadolinium enhancement whereas in 29 DCM patients (69%) gadolinium enhancement was detectable (p<0.001). 21 of the DCM patients (50%) showed midwall septal enhancement, 7 patients (17%) showed a patchy distribution of hyperenhancement and 1 patient (2%) showed enhancement typical for ischemic heart disease. In myocardial biopsy analysis, 2 patients (5%) showed persistence of viral genome, 18 patients (43%) showed inflammation and in 22 patients (52%) neither virus nor inflammation was detected. The pattern of late gadolinium enhancement and myocardial biopsy findings were not significantly correlated (p=0.854). Conclusion: MRI as a non-invasive technique cannot replace myocardial biopsy for the differential diagnosis of DCM.